Supramolecular chemistry of cyclodextrins in enzyme technology

被引:336
作者
Villalonga, Reynaldo
Cao, Roberto [1 ]
Fragoso, Alex
机构
[1] Univ Havana, Lab Bioinorgan Chem, Fac Chem, Havana 10400, Cuba
[2] Univ Matanzas, Ctr Enzyme Technol, Matanzas 44740, Cuba
[3] Univ Rovira & Virgili, Nanobiotechnol & Bioanal Grp, Dept Chem Engn, Tarragona 43007, Spain
关键词
D O I
10.1021/cr050253g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cyclodextrins (CDs) and their derivatives has been used in a range of applications related to enzymes specifically in the preparation of biosensors. The dynamic nature of host-guest interactions between CD derivatives and enzymes is exploited to increase the sensitivity of biosensing devices through signal amplification. Similarly, recycling of modified surfaces is also possible in devices containing complementary pairs of host/guest molecules due the reversible nature of the supramolecular interactions. Consequently, the use of molecular imprinting technology in CD-containing polymers should lead to improved results. One approach consists of formation of self-assembled monolayers of CDs using microcontact printing or nanoprint lithography. Currently, nanodevices for use as smart carriers is being developed that is able to target cells. In this sense, polymeric CD-containing nanocapsules with photoactive metal complexes included in the cavities can be used or the use of CdSe or CdS quantum dots capped with CDs which are able to supramolecularly associate drugs and target biomolecules while the semiconductor emits its intense fluorescent signal. The CD-enzyme interactions will also benefit biotechnological processes specifically downstream processes favoring easy recovery of valuable proteins produced by fermentation and cell culture technology.
引用
收藏
页码:3088 / 3116
页数:29
相关论文
共 321 条
  • [81] α-chymotrypsin-catalyzed degradation of desmopressin (dDAVP):: influence of pH, concentration and various cyclodextrins
    Fredholt, K
    Ostergaard, J
    Savolainen, J
    Friis, GJ
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 178 (02) : 223 - 229
  • [82] FUJITA T, 1990, J CONTROL RELEASE, V11, P149
  • [83] Neoglycoconjugates based on cyclodextrins and calixarenes
    Fulton, DA
    Stoddart, JF
    [J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (05) : 655 - 672
  • [84] Chemical and enzymatic synthesis of glycocluster having seven sialyl lewis X arrays using β-cyclodextrin as a key scaffold material
    Furuike, T
    Sadamoto, R
    Niikura, K
    Monde, K
    Sakairi, N
    Nishimura, SI
    [J]. TETRAHEDRON, 2005, 61 (07) : 1737 - 1742
  • [85] Gacche RN, 2004, J ENZYM INHIB MED CH, V19, P175, DOI [10.1080/14756360310001640472, 10.1080/1475636032000069846]
  • [86] GELLMAN SH, 1996, Patent No. 5563057
  • [87] Peracetylated β-cyclodextrin as additive in enzymatic reactions:: enhanced reaction rate and enantiomeric ratio in lipase-catalyzed transesterifications in organic solvents
    Ghanem, A
    Schurig, V
    [J]. TETRAHEDRON-ASYMMETRY, 2001, 12 (19) : 2761 - 2766
  • [88] Antioxidant therapy in acute central nervous system injury: Current state
    Gilgun-Sherki, Y
    Rosenbaum, Z
    Melamed, E
    Offen, D
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 271 - 284
  • [89] Godfrey T, 1996, IND ENZYMOLOGY
  • [90] On the preparation, characterization, and enzymatic activity of fungal protease-gold colloid bioconjugates
    Gole, A
    Dash, C
    Soman, C
    Sainkar, SR
    Rao, M
    Sastry, M
    [J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (05) : 684 - 690